Aehr Test Systems (AEHR.US) Price Target and Rating 2026/2027

103,53
4,81%
Price history for Aehr Test Systems (AEHR.US) – stock price at 103.53 $, August 2026
Aehr Test Systems stock price – price development 2026. Updated Aug 6, 2026.
Share this analysis:

Aehr Test Systems Price Target 2026: Analysts See 11% Upside

The average price target for Aehr Test Systems is $115.00. This price target represents the analysts' view of the stock price over the next 12 months. The stock may be undervalued, because the price target is higher than the current price. The stock is 11,08% below the target, which can point to potential returns within the next 12 months if the analysts' view proves right. Also consider the stock's valuation ratios such as P/E, P/S and P/B, plus the technical analysis further down the page, for the full picture.

Is Aehr Test Systems overvalued or undervalued?

Aehr Test Systems is currently undervalued with a gap of 11.1% relative to the price target.


The current price is $103.53, which places Aehr Test Systems in the undervalued category. The stock is considered undervalued when the price is below $103.50, and overvalued when the price exceeds $126.50.


The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For Aehr Test Systems, the fair value range lies between $103.50 and $126.50.


See the full price target analysis for Aehr Test Systems →

Analyst Ratings for Aehr Test Systems stock in 2026: Buy

2 analysts cover Aehr Test Systems. Analysts are mostly neutral — 50% recommend Hold. The average price target is $115.00, which gives an upside of 11.1% from the current price.

Consensus: Buy (4.00/5)
Strong Buy
1 (50%)
Hold
1 (50%)
Strong Sell Sell Hold Buy Strong Buy
4.00 out of 5 based on 2 analysts

About Aehr Test Systems – Semiconductor Equipment & Materials

Aehr Test Systems, Inc. tjener penge på at levere testløsninger til halvledere. De laver udstyr, som tester og stabiliserer chips, både før og efter de er monteret. Deres systemer er især kendt for at håndtere kiselkarbid og andre power-halvledere. Blandt deres vigtigste produkter finder man FOX-XP og FOX-NP, som kan teste hele wafers eller individuelle chips. Aehr Test Systems sælger også FOX-CP, som er en kompakt løsning til logic og hukommelseschips. De har kunder i USA, Asien og Europa. Aehr Test Systems’ teknologi bruges i alt fra mobiltelefoner og tablets til avancerede sensorer. De har udviklet FOX WaferPak Contactor, der kan teste wafers op til 300mm. Read more about the company

Key Figures for Aehr Test Systems

$ 3,6B Market cap
$ 50,0M Revenue
Semiconductor Equipment & Materials Industry
- P/E
71.69 P/S
11.89 P/B
USA Listed on exchange
aehr.com Website

What kind of stock is Aehr Test Systems?

Momentum stock

Aehr Test Systems is classified as a momentum stock with a momentum score in the top 21% of all stocks. The price has risen 0.0% over the long term.

Score Overview for Aehr Test Systems

💰 Value Score 5/100 (Very Low)
⭐ Quality Score 20/100 (Low)
🚀 Momentum Score 79/100 (High)
📊 Total Score 34/100

⚠️ 4 red flags identified 1 critical

Our analysis has identified 4 potential risk factors in Aehr Test Systems that investors should be aware of.

⚠️ Negative profit margin: The profit margin is -14.3% – the company is losing money on its operations.
⚠️ Negative return on equity: ROE is -4.2% – the company is generating a negative return for shareholders.
⚠️ High short interest: 15.6% of the shares are sold short – many professional investors are betting on price declines.
🚨 Falling earnings: Quarterly earnings have fallen 88% year over year – the company's profitability is under pressure.

📈 Valuation

The P/S ratio is 71.7 (high — the market pays a premium for the revenue). The P/B ratio is 11.9. The PEG ratio is 0.90 — below 1.0 suggests the stock is cheap relative to its growth rate.

💵 Profitability & Growth

The latest quarterly earnings grew -87.5% year over year — falling earnings.

🏦 Financial Health

The Piotroski score is 4 out of 9 — average financial health. Altman Z2 is 12.19 (healthy balance sheet — low risk). The debt-to-equity ratio (D/E) is 20.9% — low debt, a solid balance sheet.

🚀 Momentum & Short Interest

Short interest is 15.62% — very high, the market is skeptical.

Insider Trading in Aehr Test Systems 2026: The Signal Is negative

In 2026, insiders at Aehr Test Systems have made 20 transactions, all of which were sales. On a net basis, insiders took 3,666,264 $ out of the stock. Active insiders include SPORCK ALISTAIR N, ROGERS VERNON, RICHMOND DONALD P. II and others. In the short term (last 3 months), the insider signal is negative.

Short-Term Signal (3 months): Negative

Insiders have exclusively sold shares over the last 3 months.

Over the last 3 months: 0 purchases and 20 sales. A net 3,666,264 $ out of the stock.

Long-Term Signal (all transactions): Negative

Insiders have exclusively sold shares in the recent period. This can suggest management sees limited opportunity.

Across the last 20 transactions: 0 purchases and 20 sales. A net 3,666,264 $ out of the stock.

Latest sale: SPORCK ALISTAIR N sold 133 shares at 77 $ each on 2026-07-27.

Who is selling: SPORCK ALISTAIR N, ROGERS VERNON, RICHMOND DONALD P. II, Erickson Gayn, ENGINEER ADIL and others.

Latest Insider Trades in Aehr Test Systems (2026)

The table shows the last 20 reported insider transactions in Aehr Test Systems. Green rows are purchases, red rows are sales. The data is based on official filings.

Transaction date Name Type Number of shares Price per share ($) Total amount ($)
2026-07-27 SPORCK ALISTAIR N Sell 133 77 10,305
2026-07-27 ROGERS VERNON Sell 198 77 15,341
2026-07-27 RICHMOND DONALD P. II Sell 102 77 7,903
2026-07-27 Erickson Gayn Sell 1,057 77 81,896
2026-07-27 ENGINEER ADIL Sell 142 77 11,002
2026-07-20 SPORCK ALISTAIR N Sell 334 81 27,071
2026-07-16 SCOTT GEOFFREY GATES Sell 10,000 82 821,300
2026-07-14 ROGERS VERNON Sell 3,538 72 254,771
2026-07-14 RICHMOND DONALD P. II Sell 328 72 23,619
2026-07-14 Erickson Gayn Sell 3,447 72 248,218

Who is buying and selling Aehr Test Systems shares in 2026?

The following insiders have sold shares: SPORCK ALISTAIR N, ROGERS VERNON, RICHMOND DONALD P. II, Erickson Gayn, ENGINEER ADIL and others. In total, 3,666,264 $ was sold across 20 transactions. Insider trades are legal transactions in which executives and board members buy or sell shares of their own company. These transactions are reported to the SEC and are publicly available.

Aehr Test Systems Short Selling 2026: 15.6% Sold Short

Very high short interest: 15.6% of the free float
Short % of free float
15.6%
Assessment
Very high short interest
Short squeeze risk
High
Data source
SEC
Updated daily
The stock has a very high share of short selling. Between 10-20% of the freely traded shares are sold short, which points to considerable bearish sentiment. A positive earnings report or unexpectedly good news can trigger a short squeeze with sharp price gains.

What does this mean for you as an investor?
A short interest of 15.6% means that 15.6% of the freely traded shares in Aehr Test Systems have been borrowed and sold by investors betting on falling prices. On positive surprises (e.g. a strong earnings report), short sellers can be forced to buy back shares quickly to close their positions, which can cause a short squeeze with sharp price gains in a short time.

The next potential catalyst is the earnings report on 10/8/2026. With a short interest of 15.6%, the report can trigger considerable volatility.

Data is updated daily based on official filings with the SEC.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
15.6%

When Does Aehr Test Systems Report Earnings – Next Date: 10/8/2026

The next earnings report from Aehr Test Systems is scheduled for October 8, 2026, after the market closes. This report covers the third quarter (Q3), which ended on August 31, 2026.



Technical Analysis of Aehr Test Systems 2026 – Signal: Strong Buy

Overall Technical Signal: Strong Buy

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated August 6, 2026.

Technical analysis of Aehr Test Systems (AEHR.US) – RSI 56, MACD positive (bullish), daily candlestick chart August 2026
Aehr Test Systems technical analysis – candlestick chart with RSI and MACD. Updated Aug 6, 2026.

Trend Analysis of Aehr Test Systems

Aehr Test Systems is in a short-term uptrend. The price of $98.78 is 20.0% above the 20-day average ($82.33). Medium term, the picture is positive: the price is 7.7% above the 50-day average ($91.72). Long term, the stock is 82.3% above the 200-day average ($54.18), which confirms a long-term uptrend.

Golden Cross: The 50-day average (91.72) is above the 200-day average (54.18), which is a classic bullish signal for Aehr Test Systems.

Is Aehr Test Systems overbought or oversold?

Aehr Test Systems has an RSI of 56.1. The stock shows positive momentum in the upper part of the neutral zone. Combined with the positive trend, this supports the bullish picture.

MACD Analysis for Aehr Test Systems

Daily MACD: MACD is positive (1.241), which means the short-term trend is bullish (the 12-day EMA is above the 26-day EMA). MACD is above the signal line (-1.909) by 3.150, which confirms rising momentum in the uptrend.

Weekly MACD: MACD5 is positive (12.008), which indicates a broader bullish long-term trend. MACD5 is below the signal line (15.155) by 3.147, which suggests the long-term momentum is fading – the positive trend could come under pressure.

Overall MACD assessment: Both the daily and weekly trend are bullish (MACD positive). However, momentum shows signs of weakening on a weekly basis. Watch whether the trend holds.

Risk Profile for Aehr Test Systems

Aehr Test Systems has an annual standard deviation of 128.0%, which classifies the stock as extreme risk. Only risk-tolerant investors should consider this stock, because the price swings can be very large.

Overall Technical Conclusion for Aehr Test Systems

Trend: Positive. The price trades above SMA50 and SMA200.

MACD trend (zero line): Daily bullish (1.241). Weekly bullish (12.008).

MACD momentum (signal): Daily rising. Weekly falling.

RSI: 56.1 – neutral.

Technical signal: Strong Buy

The price is in an uptrend (above SMA50/SMA200) and MACD is positive on both a daily and weekly basis. Trend and MACD trend confirm each other – the strongest technical buy signal.

Frequently Asked Questions About Aehr Test Systems stock in 2026

Should you buy Aehr Test Systems stock now?
Yes, the technical signal for Aehr Test Systems is currently BUY. Aehr Test Systems trades at $103.53 as of 8/6/2026. The overall technical signal is: Strong Buy. The technical analysis shows the following: MACD is positive (bullish trend) at 1.241 with rising momentum (signal: -1.909); RSI is at 56.1 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $115.00 points to 11.1% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Aehr Test Systems stock?
The average analyst price target for Aehr Test Systems is $115.00. The current price is $103.53, which gives an upside of 11.1%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $103.50 and $126.50.
Is Aehr Test Systems a dividend stock?
No, Aehr Test Systems does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Aehr Test Systems stock?
Aehr Test Systems is rated as a stock with extreme risk. the annual standard deviation is 128.0%, which classifies the stock as extreme risk.
Is Aehr Test Systems overvalued?
No, Aehr Test Systems is considered undervalued based on the analyst price target (11.1% upside). Aehr Test Systems has the following valuation ratios: a P/S ratio of 71.7, a P/B ratio of 11.9. The analyst price target suggests that the stock is undervalued by 11.1%.
Is Aehr Test Systems overbought?
No, Aehr Test Systems is not overbought. RSI is at 56.1 (neutral zone). The technical indicators show: RSI is at 56.1 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 25.7% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next Aehr Test Systems earnings report?
Aehr Test Systems reports its next earnings on October 8, 2026. The stock currently trades at $103.53.
Is Aehr Test Systems shorted?
Yes, Aehr Test Systems is shorted with 15.6% of the free float sold short. This is a very high level of short selling, which points to considerable bearish sentiment. A positive earnings report or unexpectedly good news can trigger a short squeeze with sharp price gains. Data is updated daily based on official filings with the SEC.
Are insiders buying Aehr Test Systems stock?
No, insiders are not buying Aehr Test Systems shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 20 sales. On a net basis, 3,666,264 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 3,666,264 $ sold. Active sellers include SPORCK ALISTAIR N, ROGERS VERNON, RICHMOND DONALD P. II and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Aehr Test Systems a good stock?
Based on our total score, Aehr Test Systems is rated as a poor stock with a total score of 35 out of 100. The stock scores below average on value, quality and momentum – it sits at the lower end of the market. The score is made up of Value: 5/100, Quality: 20/100, Momentum: 79/100. In addition: analysts see 11.1% upside to the price target; technical signal: Strong Buy. Whether Aehr Test Systems is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Aehr Test Systems stock?
The outlook for Aehr Test Systems based on current data: the average analyst price target is $115.00 (+11.1%); the stock is in an uptrend (above SMA50 and SMA200); the next earnings report is due on 10/8/2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Aehr Test Systems stock rising?
Aehr Test Systems is rising right now. The technical indicators show: the price is 25.7% above the 20-day average; MACD is positive with rising momentum (bullish signal); short interest is 15.6% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Aehr Test Systems go?
The average analyst price target for Aehr Test Systems is $115.00, which corresponds to a potential gain of 11.1% from the current price of $103.53. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Aehr Test Systems fall?
We lack enough history to give a specific floor for Aehr Test Systems. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Aehr Test Systems do?
Aehr Test Systems, Inc. tjener penge på at levere testløsninger til halvledere. De laver udstyr, som tester og stabiliserer chips, både før og efter de er monteret. Deres systemer er især kendt for at håndtere kiselkarbid og andre power-halvledere. Blandt deres vigtigste prod... The company belongs to the Teknologi sector, more specifically the Semiconductor Equipment & Materials industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Aehr Test Systems as an investment.
Did Aehr Test Systems raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Aehr Test Systems. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Aehr Test Systems making money or losing money?
No, Aehr Test Systems is currently not making money — the company is losing money with a negative profit margin of -14.3%, a noticeable loss. That means the business loses money on every dollar of revenue. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Aehr Test Systems go bankrupt?
The bankruptcy risk of Aehr Test Systems is rated as low. Altman Z2 (a model for assessing financial distress) is 12.19 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 4 — which is average. Debt relative to equity is 21% (low). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Aehr Test Systems have a lot of debt?
No, Aehr Test Systems has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 21%. For the teknologi sector, anything below 80% counts as low debt. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.